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Each winter, the population and healthcare services around the globe brace themselves for 
what is usually a fairly unpredictable bombardment by a myriad of microbial pathogens. 
From an immunological perspective, human hosts are constantly modifying our defences, 
aiming to reduce the potential impact of this invisible force. We can bolster the fight by using 
annual vaccinations against influenza but by definition, we must already have an intimate 
knowledge of our enemy to generate this additional immunological shield. Sadly, newcomers 
on the microbial scene tend to slip straight through net and hit us hard. Hence the 
effectiveness of the seasonal flu vaccination waxes and wanes annually, as new (and 
previously unseen) strains of the flu virus appear (1). Despite not reaching the threshold to 
be classified as ‘living organisms,’ viruses may ultimately be our downfall; leaping from 
species to species and mutating at alarming rates, it is a wonder that we manage to keep up 
with them at all. The current global pandemic has been caused by a novel coronavirus, 
referred to as ‘severe acute respiratory syndrome coronavirus 2’ (SARS-CoV-2), which leads 
to coronavirus disease 2019 (COVID-19). Likely originating from another species (possibly a 
bat), this virus spreads via respiratory droplets, with droplets on surfaces potentially posing 
the greatest transmission threat. The magnitude of the spread of this disease is such that 
reports are outdated almost as soon as they are published. As you read this article, the 
pandemic is likely to have reached a state unimaginable when this article was drafted only a 
week ago.  
 
But this pandemic was predicted. In 2019 the Global Preparedness Monitoring Board 
produced their first annual report on global preparedness for health emergencies (2). This 
collaborative of world leaders and experts, co-convened by the World Bank Group and the 
World Health Organization in the wake of the 2014-2016 Ebola epidemic, set out to identify 
critical gaps in preparedness for a variety of global scenarios. Their first report, so perhaps 
their highest priority scenario, explored biological risks manifesting as epidemics and 
pandemics. Reading through it shortly after it was published, it felt like the script of a 
Hollywood disaster movie, but now it is an incredibly sobering prediction of what we are 
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living through today. The authors did not hold back with their predictions: “There is a very 
real threat of a rapidly moving, highly lethal pandemic of a respiratory pathogen killing 50 to 
80 million people and wiping out nearly 5% of the world’s economy.” All we can do is to hope 
that COVID-19 will not be this ‘Disease X’ but a wakeup call that makes everyone on Earth 
rethink how we are going to live alongside microbes which threaten the structure of modern 
society.  
 
A high consequence infectious disease (HCID) is defined as an acute infectious disease with 
a high case-fatality rate that has little in the way of effective prophylaxis or treatment. They 
are usually challenging to differentiate from other common infectious diseases so go 
undetected and spread rapidly through communities and, more worryingly, healthcare 
systems. The devastating results of a single patient presenting to a hospital in South Korea 
with Middle East Respiratory Syndrome coronavirus infection is a chilling tale of how an 
undiagnosed HCID can wreak havoc in a very short space of time (3). The Ebola outbreak of 
2014-2016 triggered NHS England to think about a more robust approach to dealing with 
HCIDs, and the HCID network was formed in England. Dividing HCIDs into contact (primarily 
the viral haemorrhagic fevers) and airborne (respiratory droplet or aerosol transmission) 
(Table 1), Hospitals were commissioned to be designated tertiary referral centres for 
patients with a positive diagnosis of an HCID. Resources were allocated to prepare these 
centres to safely manage infected patients. A multidisciplinary approach was taken to 
provide a comprehensive team at each centre, led by those who would be called on to 
deliver that care: specialists in infectious diseases and intensive care medicine. The role of 
intensive care medicine in HCIDs is crucial, as was seen in the Ebola outbreak (4) and 
current COVID-19 pandemic (5, 6). Each of the HCID centres has an intensive care lead, 
whose role is to coordinate preparedness locally and link the intensive care units (ICUs) 
ensuring a flow of information and learning. The HCID ICUs are constantly ready to activate 
their plans and accept referrals from across England.  
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“The best laid plans…” Before the HCID network there was little in the way of a coordinated 
national plan to deal with HCIDs, particularly in terms of capacity and joined up thinking. Its 
creation brought together geographically separated centres to share ideas and approaches. 
It was ready for action. But how do four hospitals, in the middle of the annual winter bed 
crisis, deal with a global airborne pandemic? The short answer is, they don’t. Plan B has 
already been initiated, which is that every ICU in the country readies itself, in a matter of 
days, to be an airborne HCID centre. The scale of what we have witnessed in China and 
Italy has left all of us with a lingering sense of dread. The question of whether this is about to 
happen in the UK and, if so, how bad it is going to be will likely have been answered by the 
time this goes to print. In this brief calm before the storm, everyone needs to ready 
themselves for the inevitable. The ask is unthinkable though,  
 
The current ask was perhaps previously unthinkable: to train up every frontline member of 
staff in the use of personal protective equipment (PPE); and to draw up detailed plans to 
Where does one even start with such a task?  
 
Top-down leadership and guidance in parallel with bottom-up dissemination of expertise and 
experience is essential in this preparatory phase, in order to get things right. We require 
clear messaging from those with a national view of the situation, filtered down through Royal 
Colleges, Faculties, Societies, specialties, Trusts and departments. We must avoid the 
natural instinct to all run in opposite directions when disaster strikes, producing conflicting 
guidance and messaging. We need to banish all thoughts of the second law of 
thermodynamics and prevent an increase in entropy. Calmness and a rational approach to 
dealing with this crisis will ultimately be our strength, as opposed to each and every hospital 
in the country raising the drawbridge and fighting it alone in their own unique way. Such talk 
is easy, but what are we actually going to do? As intensivists at HCID centres we have been 
at an unfair advantage, having readied ourselves for this long ago. That said, we were ready 
to admit one or two patients at each centre, isolate them and manage them safely, but this 
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state of readiness never extended to the scenario of a pandemic. So, whilst we had a head-
start, the playing field is rapidly being levelled. Our role now is to share what experience and 
expertise we have in the management of airborne HCID patients (be that suspected or 
confirmed) in order to turn every ICU in the country into an airborne HCID centre. Data now 
being published from Italy confirm that ICUs will play a central role in this pandemic, so as a 
specialty it is time for us to step up and deliver everything we have to see us through this (7).  
 
Converting your already busy ICU into an HCID-ready environment and ensuring the 
preparedness of your staff will not be easy. The task is made more difficult by the rapidly 
changing landscape of this pandemic and the framework in which the country is dealing with 
it. Guidance is updated daily and we must respond to it as best we can. In times like this one 
cannot expect to be handed a standard operating procedure that can be followed to the 
letter to complete the task. As we learn more about this disease and move through different 
stages of contagion in the community the plans must be rapidly reassessed and adapted to 
achieve success. Think of the system like the Cabinet War Rooms, seeking up to date 
intelligence on a complex battle being fought on multiple fronts. Those at the front line are 
desperate to know the overall game plan yet, at the same time, how to capture the hill right 
in front of them. This represents a near impossible juggling act of disseminating enough 
information to keep those at the sharp end in the loop, but not overwhelming them with the 
plans for the final assault. In this analogy it is the generals who maintain the two way flow of 
information and ultimately win the war. Our Generals in this pandemic must therefore be 
ready for what we are about to face.  
 
Guidance from various bodies is now hitting our screens daily, combining the knowledge and 
experience of a wide variety of individuals, to guide the country through this difficult time. 
Little of what can be produced for this purpose fits our usual rigorous evidence-based 
approach. It has to be formulated from what little evidence there is available, the 
experiences endured by our colleagues abroad who are already faced with overwhelming 
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numbers of patients, and a healthy dose of common sense. It is important that we begin to 
understand that this guidance is likely to change over time, so we need pay attention to what 
is going on around as well as providing care to patients under exceptionally difficult 
circumstances. Rather than replicate the guidance already being produced, we would advise 
you to keep a watchful eye on the following websites:  
 
• National emergency critical care committee: COVID-19: https://icscovid.com 
• A working collaboration formed by The Faculty of Intensive Care Medicine, Intensive 
Care Society, Association of Anaesthetists and Royal College of Anaesthetists: 
https://icmanaesthesiacovid-19.org 
• Emergency Preparedness, Resilience and Response (EPRR): 
https://www.england.nhs.uk/coronavirus/  
 
The National Emergency Committee for Critical Care has now been formed in the UK to 
bring together disparate strands of work into one framework for the UK. However, one of the 
most important thing we should all read is the Intensive Care Society wellbeing resource 
library: https://www.ics.ac.uk/ICS/Education/Wellbeing/ICS/Wellbeing.aspx?hkey=92348f51-
a875-4d87-8ae4-245707878a5c. What we are about to face is unthinkable and will take a 
toll on us all. Our psychological wellbeing is paramount. We spend a great deal of time 
learning how to don and doff PPE in order to remain physically well, yet virtually no time 
considering how to cope with the experiences we will all endure. Please use the resources 
on this superb website, print out the posters, pin them up and emphasise the importance of 
looking out for each other’s welfare.  
 
This is intensive care’s time to show the country that we are ready and able to face the 




Table 1. A list of contact and airborne high consequence infectious diseases been agreed 
by Public Health England (PHE) and the NHS England HCID programme 
 
Contact HCID Airborne HCID 
Argentine haemorrhagic fever (Junin virus) Andes virus infection (hantavirus) 
 
Bolivian haemorrhagic fever (Machupo 
virus) 
Avian influenza A H7N9 and H5N1 
 
Crimean Congo haemorrhagic fever 
(CCHF) 
Avian influenza A H5N6 and H7N7 
 
Ebola virus disease (EVD) Middle East respiratory syndrome (MERS) 
 
Lassa fever Monkeypox 
Lujo virus disease Nipah virus infection 
Marburg virus disease (MVD) Pneumonic plague (Yersinia pestis) 
Severe fever with thrombocytopaenia 
syndrome (SFTS) 
Severe acute respiratory syndrome 
(SARS)* 
 Coronavirus disease (COVID-19) 
 
Adapted from https://www.gov.uk/guidance/high-consequence-infectious-diseases-hcid 
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Table 2. High consequence infectious diseases centres in England 
 
Contact HCID Treatment Centres in England 
Royal Free London  
Newcastle Royal Victoria Infirmary  
 
Airborne HCID Treatment Centres in England 
Guy’s and St Thomas’ NHS Foundation Trust (adult and paediatric services) 
Royal Free London NHS Foundation Trust, with a paediatric service provided by Imperial 
College Healthcare NHS Foundation Trust 
Royal Liverpool and Broadgreen University Hospitals NHS Trust, with a paediatric service 
provided by Alder Hey Children’s NHS Foundation Trust 
Newcastle upon Tyne Hospitals NHS Foundation Trust (adult and paediatric services) 
 
Adapted from https://www.gov.uk/guidance/high-consequence-infectious-diseases-hcid  
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